MAY 17, 2018 10:00 AM PDT

A comprehensive workflow solution from gene synthesis to purified proteins

Speakers
  • Sr. Manager R&D, Thermo Fisher Scientific
    Biography
      Michael Liss, Sr. Manager R&D, received his PhD in 2000 from University of Regensburg & Boulder gaining expertise in virology, molecular biology and directed evolution. 2000-2002: Post Doc in Biosensoring with aptamers. 2002-2012: Scientist in R&D at GeneArt GmbH. 2012-2014: Sr. Manager R&D at Life Technologies, since 2014: Sr. Manager R&D at Thermo Fisher Scientific. During his work in synthetic biology and gene synthesis Michael has setup & managed the directed evolution unit for more than five years. He further advanced the progress of economic and reliable gene synthesis and installed the gene-to-protein service. Today, he is responsible for R&D projects including process development, portfolio accretion and novel applications of synthetic biology.

    Abstract:

    Reliable expression of recombinant proteins in human or CHO cells is essential for many aspects of biomedical research and drug development but is often hampered by low expression yields that limit subsequent structural and functional analyses. The full portfolio of Thermo Fisher Scientific, from GeneArt™ gene synthesis to optimized mammalian expression systems, offers researchers the unique opportunity to perfect their gene expression results. Our proprietary sequence optimization algorithm GeneOptimizer™ enhances the sequence through a parallel multiparameter approach. To further maximize protein yield, you can choose from our best serum-free Gibco™ FreeStyle™ or Invitrogen™ Expi293™ and ExpiCHO™ expression systems. This holistic approach - from electronic gene sequence or accession number to the purified protein - is the most efficient way to exploit your gene-to-protein workflow for highest performance, either by purchasing reagents for internal work or outsourcing the entire workflow as a highly customized service to the GeneArt™ protein team. The presentation explains the basics of gene optimization and gene synthesis and how the combination with the best expression system produces unsurpassed expression reliability and protein yield.


    Show Resources
    You May Also Like
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    NOV 18, 2019 07:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    MAY 23, 2019 09:00 AM PDT
    C.E. CREDITS
    MAY 23, 2019 09:00 AM PDT
    DATE:  May 23, 2019TIME:   9:00am PDT, 12:00pm EDT Although mesenchymal stem/stromal cells (MSCs) chondrogenic differentiation has been thoroughly investigated...
    Loading Comments...
    Show Resources